Name | 3,4-dihydro-2H-2,6-naphthyridin-1-one |
---|---|
Synonyms |
3,4-dihydro-2H-[2,6]naphthyridin-1-one
Tetrahydro-2,6-naphthyridin-1-on 3,4-dihydro-2,6-naphthyridin-1(2H)-one 1,2,3,4-Tetrahydro-2,6-naphthyridin-1-on 1,2,3,4-TETRAHYDRO-2,6-NAPHTHYRIDIN-1-ONE |
Molecular Formula | C8H8N2O |
---|---|
Molecular Weight | 148.16200 |
Exact Mass | 148.06400 |
PSA | 41.99000 |
LogP | 0.69630 |
~27% 58553-56-3 |
Literature: NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 1018 ; |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 58553-56-3 |
Literature: Meiji Seika Kaisha, Ltd. Patent: EP1180514 A1, 2002 ; Location in patent: Example 104 ; |